NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/13/2024
Back to search
Official data from USPTO
JUXTAPID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/07/2025
Trademark type
Word
Nice classes
5
Filing date
12/14/2012
Registration date
04/01/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2024
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/28/2013
First use in commerce
01/28/2013
Drawing code
4
Owner type
03
Owner location
DUBLIN, IE
Examiner
BEVERLY, JOSETTE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AMRYT PHARMACEUTICALS INC.
Aegerion Pharmaceuticals, Inc.
Representatives
Richard Todd Armstrong, Ph.D. CLARK + ELBING LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERSIN PARTICULARHYPERLIPIDEMIA
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/13/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/13/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/05/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/23/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/02/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/02/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/02/2020
E815
TEAS SECTION 8 & 15 RECEIVED
03/10/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/01/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/18/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/25/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/24/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/24/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/11/2014
DPCC
DIVISIONAL PROCESSING COMPLETE
02/11/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/09/2014
IUAF
USE AMENDMENT FILED
01/09/2014
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2014
DRRR
DIVISIONAL REQUEST RECEIVED
12/17/2013
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/17/2013
EISU
TEAS STATEMENT OF USE RECEIVED
12/17/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/09/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2013
PUBO
PUBLISHED FOR OPPOSITION
05/14/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/06/2013
ALIE
ASSIGNED TO LIE
04/03/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2013
DOCK
ASSIGNED TO EXAMINER
03/30/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2013
NWAP
NEW APPLICATION ENTERED
12/18/2012
Continuous trademark protection
Get notified about every new filing that threatens JUXTAPID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.